ValiRx Past Earnings Performance

Past criteria checks 0/6

ValiRx has been growing earnings at an average annual rate of 3.5%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 95.1% per year.

Key information

3.5%

Earnings growth rate

72.9%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate95.1%
Return on equity-58.9%
Net Margin-20,554.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ValiRx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:EAJF Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-220
31 Mar 240-220
31 Dec 230-220
30 Sep 230-220
30 Jun 230-221
31 Mar 230-221
31 Dec 220-221
30 Sep 220-220
30 Jun 220-220
31 Mar 220-220
31 Dec 210-210
30 Sep 210-110
30 Jun 210-110
31 Mar 210-110
31 Dec 200-110
30 Sep 200-221
30 Jun 200-221
31 Mar 200-221
31 Dec 190-221
30 Sep 190-321
30 Jun 190-321
31 Mar 190-421
31 Dec 180-432
30 Sep 180-422
30 Jun 180-322
31 Mar 180-322
31 Dec 170-312
30 Sep 170-422
30 Jun 170-522
31 Mar 170-522
31 Dec 160-522
30 Jun 160-311
31 Mar 160-211
31 Dec 150-212
30 Sep 150-322
30 Jun 150-322
31 Mar 150-322
31 Dec 140-322
30 Sep 140-312
30 Jun 140-211
31 Mar 140-311
31 Dec 130-312

Quality Earnings: EAJF is currently unprofitable.

Growing Profit Margin: EAJF is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EAJF is unprofitable, but has reduced losses over the past 5 years at a rate of 3.5% per year.

Accelerating Growth: Unable to compare EAJF's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EAJF is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


Return on Equity

High ROE: EAJF has a negative Return on Equity (-58.92%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies